Toxicology Track

Weekly Newsletter of the MSU Center for Integrative Toxicology
Director: Norbert Kaminski/Editor: Lois Furry

October 1 , 2007, Vol. 30, Number 35

Seminars this week/Seminars upcoming/Conferences/Positions

Seminars this week

The Respiratory Research Initiative presents Dr. Marcus Mall, University of Heidelbert, Germany, to speak on “The Role of Airway Surface Dehydration in the Pathogenesis and as a Therapeutic Target of Cystic Fibrosis Lung Disease” on Tuesday, October 2, 2007 at 11:30 a.m. in 162 Food Safety and Toxicology.

The Cell and Molecular Biology Program presents Sheenu Mittal, MSU, to speak on “Interaction of a Response Regulator and a CRP-family Protein in Regulation of a C-Signal-Dependent Promoter, 4400, During Myxococcus Xanthus Development” on Tuesday, October 2, 2007 at 1 p.m. in 2245 Biomedical Physical Sciences.

The Microbiology and Molecular Genetics Department presents Shelagh Ferguson-Miller, chairperson, to speak on “Cytochrome c Oxidase from Rhodobacter Sphaeroide, A Model for Mitochondrial Energy Transduction” on Tuesday, October 2, 2007 at 4:10 p.m. in 1415 Biomedical Physical Sciences.

The Biochemistry and Molecular Biology Department presents Terri Goss Kinzy, University of Medicine & Dentistry of New Jersey, to speak on "Coordinated Function of Translation Elongation Factor 1A in Actin Organization and Protein Synthesis" on Thursday, October 4, 2007 at 11:30 a.m. in 101 Biocemistry.

Seminars upcoming

The CIT is hosting a lecture by Albert E. Munson, director of the Health Effects Laboratory Division for the National Institute of Occupational Safety and Health, at noon on Thursday, November 8, 2007 at the Holden Hall Hunt Club. Lunch is included. Reservations required at tox@msu.edu.

Conferences and other events

Students in the Environmental and Integrative Toxicological Sciences program are reminded of the requirement for training in research ethics offered by the University. Specific information and a complete description of all the sessions in the Responsible Conduct of Research Seminar Series is available at the series' web site: http://grad.msu.edu/all/respconduct.htm

The College of Veterinary Medicine’s Phi Zeta Research Day will be held on Friday, October 12, 2007. The activities include 29 oral presentations and 59 poster presentations by students and faculty. Dr. Scott Weese, from the Ontario Veterinary College, will give a keynote addresss “One Medicine; Emerging Infections Diseases and an Old Concept” at 3 p.m. in G-a50 Vet. Med. Center. For more information, go to http://cvm.msu.edu/org/rgs/phizetaday.html.

The University of Michigan Center for Risk Science and Communication presents the 2007 Bernstein Symposium: Nanotechnology and Health: Evidence and Impact on October 25-26, 2007 at the Biomedical Science Research Building (BSRB) 109 Zina Pitcher, Ann Arbor, Michigan. The Center, under the leadership of Dr. Martin Philbert, has put together a program that will bring together leading scientists and policymakers to examine the emerging field of nanotechnology, its potential impact on human health, and the growing debate over whether and how to regulate nanotechnology products. A broad array of expert speakers will present including Christine Todd Whitman, former MI U.S. Rep. Joe Schwartz, Risk Perception law expert Dan Kaham, EPA administrator George Gray, NIOSH Nano Group member David Warheit, and NPR Science Reporter Richard Harris. For more information, go to
http://www.sph.umich.edu/riskcenter/index.htm.

The following MSU Statistics workshops are now accepting registrants: “Introduction to Regression Analysis” on October, 5, 2007; “Intermediate Data Analysis Using SPSS on October 19, 2007; and “Mixed Model Analysis of Research Data” on November 2, 2007. For detailed information and to register, go to http://www.cstat.msu.edu/.

The American Society for Cell Biology 47th Annual Meeting will take place Dec. 1-5, 2007 in Washington, D.C. Late abstracts will be accepted until Oct. 4, 2007. For more information, go to http://www.ascb.org/meetings/index.cfm.

Experimental Biology 2008 will take place April 5-9, 2008 in San Diego, California. Abstracts are being accepted until November 7, 2007. For more information, go to http://www.eb2008.org/.

Positions

The Department of Chemistry at the University of North Texas seeks a candidate for a faculty position at the Associate or Full Professor level. The candidate must hold a Ph.D. in chemistry. Post-doctoral experience is preferred. The successful candidate is expected to establish a strong, nationally recognized research program that will attract major extramural funding in their respective area of expertise and will be allocated competitive start-up funds. The candidate should also have the ability to teach graduate and undergraduate courses in their field of specialization. The specific areas of research are open, but preference will be given to candidates having research interests that add to and complement the Department’s Forensic program. For additional information or to be considered for the position, please contact Dr. Teresa D. Golden (ChemFacSearch@unt.edu), Chair, Senior Faculty Search Committee, Department of Chemistry, P.O. Box 305070, University of North Texas, Denton, TX 76203. Applications should include a cover letter describing qualifications, a curriculum vitae, and a narrative of research plans. Applicants should also arrange for three letters of recommendation to be sent to the committee chair.

Cabot Corporation in Billerica, MA, seeks applicants for a regulatory toxicologist position to develop and implement risk reduction strategies for new and existing products. Expertise in inhalation toxicology is highly desirable and expertise in mammalian toxicology methods is required. For more information, go to http://w1.cabot-corp.com/controller.jsp?R=1805.

The National Cancer Institute is recruiting for a Supervisory Pharmacologist/Toxicologist/Chemist to manage and coordinate a contract program for the toxicological evaluation of selected new therapeutic agents. The Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis of the National Cancer Institute is responsible for planning, directing and evaluating a collaborative, extramural, contract-supported program in anticancer drug and vaccine development to provide information on preclinical pharmacology and toxicology data used in formulating recommendations for doses, dose escalation schemes and treatment schedules for clinical trial. This Branch includes a staff of at least 8, all of which are professionals at the GS-13/14 level. Post-doctoral Fellows and other contract staff also are assigned to the Branch periodically to supplement current NCI staff. The incumbent also serves as the scientific director of the Laboratory of Human Toxicology and Pharmacology in the NCI’s Frederick Cancer Research Facility that is supported by the SAIC contract. The Branch Chief determines the overall requirements for pharmacological and toxicological studies of agents in the Division of Cancer Treatment and Diagnosis’ drug discovery and development programs and closely coordinates the functions of the Branch with other related program components, including the Biological Resources Branch, Biological Testing Branch, Drug Synthesis and Chemistry Branch, Natural Products Branch, Pharmaceutical Resources Branch, Regulatory Affairs Branch (CTEP), the Investigational Drug Branch (CTEP) and various components of the CCR, especially the Molecular Targets Program. For more information and to apply, go to http://usajobs.opm.gov. Use job announcement: NCI-07-208626-DE.